AAAAAA
Results:
1-13
|
Results: 13
Authors:
Berntorp, E
Petrini, P
Dockter, G
Tengborn, L
Wendisch, I
Eberl, W
Aumann, V
Frade, G
Seliger, I
Engl, W
Ehrlich, H
Citation: E. Berntorp et al., An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients, HAEMOPHILIA, 7(4), 2001, pp. 360-363
Authors:
Astermark, J
Tengborn, L
Hedner, U
Berntorp, E
Citation: J. Astermark et al., Anti- and procoagulant activities in factor VII-deficient subjects, THROMB RES, 101(6), 2001, pp. 435-440
Authors:
Poon, MC
d'Oiron, R
Hann, I
Negrier, C
de Lumley, L
Thomas, A
Karafoulidou, A
Demers, C
Street, A
Huth-Kuhne, A
Petrini, P
Fressinaud, E
Morfini, M
Tengborn, L
Marques-Verdier, A
Musso, R
Devecioglu, O
Houston, DS
Lethagen, S
Van Geet, C
von Depka, M
Berger, C
Beurrier, P
Britton, HA
Gerrits, W
Guthner, C
Kuhle, S
Lorenzo, JJ
Makris, PE
Nohe, N
Paugy, P
Pautard, B
Torchet, MF
Trillot, N
Vicariot, M
Wilde, J
Winter, M
Chambost, H
Ingerslev, J
Peters, M
Strauss, G
Citation: Mc. Poon et al., Use of recombinant factor VIIa (NovoSeven (R)) in patients with Glanzmann thrombasthenia, SEM HEMATOL, 38(4), 2001, pp. 21-25
Authors:
Ljung, R
Petrini, P
Tengborn, L
Sjorin, E
Citation: R. Ljung et al., Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity, BR J HAEM, 113(1), 2001, pp. 81-86
Authors:
Lindgren, A
Wadenvik, H
Tarkowski, A
Tengborn, L
Citation: A. Lindgren et al., Does peroral administration of factor VIII induce oral tolerance in patients with acquired haemophilia A?, THROMB HAEM, 83(4), 2000, pp. 632-633
Authors:
Knobe, KE
Villoutreix, BO
Tengborn, L
Petrini, P
Ljung, RCR
Citation: Ke. Knobe et al., Factor VIII inhibitors in two families with mild haemophilia A: Structuralanalysis of the mutations, HAEMOSTASIS, 30(5), 2000, pp. 268-279
Authors:
Tengborn, L
Citation: L. Tengborn, von Willebrand disease in Sweden: demography and treatment, HAEMOPHILIA, 5, 1999, pp. 75-76
Authors:
Wahlander, K
Tengborn, L
Hellstrom, M
Olmarker, AH
Peterson, LE
Stigendal, L
Larson, G
Citation: K. Wahlander et al., Comparison of various D-dimer tests for the diagnosis of deep venous thrombosis, BL COAG FIB, 10(3), 1999, pp. 121-126
Authors:
Hahn, L
Mattsson, LA
Andersson, B
Tengborn, L
Citation: L. Hahn et al., The effects of oestrogen replacement therapy on haemostatic variables in postmenopausal women with non-insulin-dependent diabetes mellitus, BL COAG FIB, 10(2), 1999, pp. 81-86
Authors:
Kjellberg, U
Andersson, NE
Rosen, S
Tengborn, L
Hellgren, M
Citation: U. Kjellberg et al., APC resistance and other haemostatic variables during pregnancy and puerperium, THROMB HAEM, 81(4), 1999, pp. 527-531
Authors:
Astermark, J
Petrini, P
Tengborn, L
Schulman, S
Ljung, R
Berntorp, E
Citation: J. Astermark et al., Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized, BR J HAEM, 105(4), 1999, pp. 1109-1113
Authors:
Rosen, S
Wejkum, L
Billing-Claeson, S
Ghosh, R
Grdic, K
Chmielewska, J
Meijer, P
Kluft, C
Tengborn, L
Conkie, J
Walker, I
Citation: S. Rosen et al., Evaluation of a bioimmunoassay for t-PA activity and its relation to PAI-1activity and antigen levels, FIBRINOL PR, 12(6), 1998, pp. 340-346
Authors:
Tengborn, L
Hansson, S
Fasth, A
Lubeck, PO
Berg, A
Ljung, R
Citation: L. Tengborn et al., Anaphylactoid reactions and nephrotic syndrome - a considerable risk during factor IX treatment in patients with haemophilia B and inhibitors: a report on the outcome in two brothers, HAEMOPHILIA, 4(6), 1998, pp. 854-859
Risultati:
1-13
|